Two link board Xiamen Kingdomway Group Company(002626) : at present, intermediate P2 has not been commercially produced

Xiamen Kingdomway Group Company(002626) issued the announcement of abnormal fluctuations in stock trading. The company has no orders for intermediate P2 at present, and there is no indication that orders can be obtained in the future. If intermediate P2 cannot be sold directly or indirectly to Pfizer and its related companies in the industrial chain, or to the manufacturers of related generic drugs (if any), the project investment plan may be terminated Risks of partial termination, change of investment plan and income not meeting expectations. At present, intermediate P2 has not been commercially produced in the company and is not expected to have a significant impact on the company’s performance in 2022.